Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial
暂无分享,去创建一个
G. Daniels | O. Guntinas-Lichius | M. Milhem | T. Day | C. Guiducci | E. Cohen | E. Gamelin | A. Algazi | M. Strother | D. Wong | E. Whitman | S. Deva | M. Jameson | M. Almubarak | R. Janßen | M. Chisamore | L. Nabell | C. Obiozor | T. Bagulho | Josse Gomez-Romo | E. Cohen | C. Obiozor